API & Bulk Drug Synthesis Execution
Master formula execution, solvent recovery tracking, yield mass balance, and mother liquor logging engineered for Hyderabad's synthetic chemistry plants.
Loading…
DMS, LIMS, LMS, QMS & EBR for Hyderabad's bulk drug, API, vaccine, and formulation corridor
Hyderabad is India's bulk drug and vaccine capital, home to world-class manufacturing across Genome Valley, Bachupally, Jeedimetla, Pashamylaram, and Patancheru. Novaqis delivers high-performance GxP digital quality operations (DMS, LIMS, LMS, QMS, and BRM) with 21 CFR Part 11 validation, sovereign on-premise installation, and transparent enterprise site licensing.
Product preview
Sample tracking, instrument acquisition, and stability pull schedules
LIMS / Lab Dashboard
Laboratory Testing & Sample Workload Hub
Technical Architecture
Each capability is built directly into our shared regulatory fabric, eliminating integration glue and validation rework.
Master formula execution, solvent recovery tracking, yield mass balance, and mother liquor logging engineered for Hyderabad's synthetic chemistry plants.
22-module paperless LIMS with InstrumentLink Instrument SDK for bidirectional chrom / non-chrom interlinking, USP <711> dissolution, and 2-phase OOS root-cause investigations.
Run 100% air-gapped on your private factory servers with offline ES256 cryptographic licensing and zero external cloud data dependency.
Predictable plant-wide enterprise licensing covering unlimited operators, analysts, QA reviewers, and contract staff without user seat taxes.
Compliance & control
Audit trails, electronic signatures, role-based access, and deployment choices designed for GxP validation, not bolted on after the fact.
Real-time calculation of theoretical yields, solvent recovery distillation logs, and LOD parameters.
IDAS plus InstrumentLink connect HPLC, GC, balances, and other instruments for zero-transcription test recording across major LIMS.
Dual-credential e-signatures, immutable ALCOA+ audit trails, and GAMP 5 Category 4 CSV documentation.
Enterprise Outcomes
Measured operational breakthroughs across quality, manufacturing, and regulatory compliance.
100% elimination of paper batch binders and manual calculation errors
Turnkey US FDA 21 CFR Part 11 and CDSCO Schedule M compliance
Rapid 6-week plant rollout across multi-site Hyderabad manufacturing units
Dedicated local deployment and validation support
FAQ